Nitric oxide participates in cataract development in selenite-treated rats

Y Ito1, T Nabekura, M Takeda

  • 1School of Pharmaceutical Sciences, Kinki University, Osaka, Japan.

Current Eye Research
|July 20, 2001
PubMed
Abstract

Insights

Nitric oxide synthase (NOS) inhibitors prevented selenite-induced cataracts in rats. This suggests nitric oxide plays a key role in cataract development, offering potential therapeutic targets.

Area of Science:

  • Ophthalmology
  • Biochemistry
  • Pharmacology

Background:

  • Cataracts are a leading cause of blindness.
  • Selenite-induced cataracts in rats serve as a model for studying cataractogenesis.
  • The role of nitric oxide in this model is not fully understood.

Purpose of the Study:

  • To investigate the role of nitric oxide in selenite-induced cataracts.
  • To examine the effects of nitric oxide synthase (NOS) inhibitors on cataract development.

Main Methods:

  • Selenite was injected to induce cataracts in rats.
  • Rats were pretreated with NOS inhibitors (L-NAME, aminoguanidine) or vehicle.
  • Lens opacity, glutathione, Ca2+ content, and nitrite levels were measured.
  • NOS expression and activity were assessed.

Main Results:

  • NOS inhibitors significantly inhibited lens opacification.
  • L-arginine, a NOS substrate, accelerated cataract development.
  • Nitrite levels and NOS expression increased within one day of selenite injection.

Conclusions:

  • Nitric oxide synthase inhibitors effectively prevent selenite-induced cataracts.
  • Nitric oxide plays a crucial role in the pathogenesis of selenite-induced cataracts.